Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID-19 in the United States: a retrospective cohort study.
Deitelzweig S, Luo X, Nguyen JL, Malhotra D, Emir B, Russ C, Li X, Lee TC, Ferri M, Wiederkehr D, Reimbaeva M, Barnes GD, Piazza G. Deitelzweig S, et al. J Thromb Thrombolysis. 2022 May;53(4):766-776. doi: 10.1007/s11239-022-02644-2. Epub 2022 Apr 30. J Thromb Thrombolysis. 2022. PMID: 35489004 Free PMC article.
Venous thromboembolism in the US: does race matter?
Deitelzweig SB, Lin J, Johnson BH, Schulman KL. Deitelzweig SB, et al. J Thromb Thrombolysis. 2011 Feb;31(2):133-8. doi: 10.1007/s11239-010-0503-3. J Thromb Thrombolysis. 2011. PMID: 20658176
Estimation of the impact of warfarin's time-in-therapeutic range on stroke and major bleeding rates and its influence on the medical cost avoidance associated with novel oral anticoagulant use-learnings from ARISTOTLE, ROCKET-AF, and RE-LY trials.
Amin A, Deitelzweig S, Jing Y, Makenbaeva D, Wiederkehr D, Lin J, Graham J. Amin A, et al. Among authors: deitelzweig s. J Thromb Thrombolysis. 2014;38(2):150-9. doi: 10.1007/s11239-013-1048-z. J Thromb Thrombolysis. 2014. PMID: 24477787 Review.
Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in "real-world" clinical practice. A propensity-matched analysis of 76,940 patients.
Li XS, Deitelzweig S, Keshishian A, Hamilton M, Horblyuk R, Gupta K, Luo X, Mardekian J, Friend K, Nadkarni A, Pan X, Lip GYH. Li XS, et al. Among authors: deitelzweig s. Thromb Haemost. 2017 Jun 2;117(6):1072-1082. doi: 10.1160/TH17-01-0068. Epub 2017 Mar 16. Thromb Haemost. 2017. PMID: 28300870 Free PMC article.
113 results